Global Longlife Hospital appoints Hiren Mandaliya as Independent Director

1 min read     Updated on 26 Jun 2026, 05:04 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Global Longlife Hospital and Research Ltd announced the appointment of Hiren Mandaliya as a Non-Executive Independent Director for a five-year term from March 31, 2026, to March 30, 2031. The appointment was approved by shareholders at the Annual General Meeting on June 25, 2026. Mandaliya, a Chartered Accountant, brings expertise in accounting and taxation.

powered bylight_fuzz_icon
44019260

*this image is generated using AI for illustrative purposes only.

Global Longlife Hospital and Research Ltd has appointed Hiren Mandaliya as a Non-Executive Independent Director for a period of five years. The appointment, effective from March 31, 2026, to March 30, 2031, was approved by shareholders at the Annual General Meeting held on June 25, 2026, based on the recommendation of the Board of Directors.

Mandaliya is a qualified Chartered Accountant with expertise in accounting, taxation, compliances, finalization of accounts, filing of returns, assessment proceedings, and representation before tax authorities. The disclosure confirms that he is not related to any director of the company and is not debarred from holding the position of director by any SEBI order or other authority.

The appointment was disclosed to the BSE under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company provided the necessary details in accordance with Schedule III of the SEBI LODR Regulations and the relevant SEBI Master Circular.

Appointment Details

Detail Information
Name of Director Mr. Hiren Mandaliya
DIN 11636452
Designation Non-Executive Independent Director
Date of Appointment June 25, 2026
Term of Office Five Years (March 31, 2026 to March 30, 2031)
Qualification Chartered Accountant

Historical Stock Returns for Global Longlife Hospital & Research

1 Day5 Days1 Month6 Months1 Year5 Years
+3.86%+15.56%-4.56%-49.39%-52.48%-91.66%

How will Mr. Mandaliya's financial expertise influence the company's future fiscal strategies and cost management?

What specific governance improvements can shareholders expect following the addition of this independent director?

Does this appointment signal a shift in the company's focus towards stricter regulatory compliance and transparency?

Global Longlife Hospital & Research
View Company Insights
View All News
like16
dislike

Global Longlife Hospital re-appoints Manasvi Manu Thapar as Independent Director

2 min read     Updated on 26 Jun 2026, 04:57 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Global Longlife Hospital and Research Limited re-appointed Mr. Manasvi Manu Thapar as Independent Director for a second term of five years from September 10, 2026, to September 09, 2031, following shareholder approval at the AGM on June 25, 2026. All seven resolutions, including the re-appointment of Mr. Dhruv Jani as Managing Director and other key approvals, passed with 100% votes in favour.

powered bylight_fuzz_icon
43926047

*this image is generated using AI for illustrative purposes only.

Global Longlife Hospital and Research Limited re-appointed Mr. Manasvi Manu Thapar as Independent Director for a second term of five years, commencing from September 10, 2026, to September 09, 2031, following shareholder approval at its 15th Annual General Meeting (AGM) on June 25, 2026. The AGM, which commenced at 11:00 A.M. and concluded at 11:08 A.M., saw the re-appointment approved based on the Board of Directors' recommendation. Mr. Thapar is a legal professional with 10 years of experience and operates his own practice under the firm name Candour Legal.

Voting Results and Key Resolutions

Shareholders approved all seven resolutions through remote e-voting, with 36,88,990 votes cast in favour of every proposal, representing 100% of the total valid votes polled. The scrutinizer's report confirmed the requisite majority for all resolutions. No votes were cast during the physical AGM, as voting was conducted solely via remote e-voting from June 22, 2026, to June 24, 2026. The total number of shareholders on the record date of May 30, 2026, was 1158.

Sr. No Resolution Description Type Votes In Favour % of Votes
1 Adoption of Audited Financial Statements for FY26 Ordinary Resolution 36,88,990 100%
2 Re-appointment of Ms. Sucheta Jani (DIN: 06502321) Ordinary Resolution 36,88,990 100%
3 Appointment of Mr. Hiren Mandaliya (DIN: 11636452) as Independent Director Special Resolution 36,88,990 100%
4 Approval of Change in Name of the Company Special Resolution 36,88,990 100%
5 Alteration of Object clause of MOA Special Resolution 36,88,990 100%
6 Re-appointment of Mr. Dhruv Jani (DIN: 03154680) as Managing Director Special Resolution 36,88,990 100%
7 Re-appointment of Mr. Manasvi Manu Thapar (DIN: 07486932) as Independent Director Special Resolution 36,88,990 100%

Meeting and Compliance Details

The meeting was chaired by Mr. Dhruv Jani, Managing Director. Ms. Insiya Nalawala, Practicing Company Secretary, served as the scrutinizer for the e-voting process, with results witnessed by Mr. Mustansir Bhopali and Mr. Moiz Ezzi. Promoters and promoter groups held 24,01,990 shares, while public non-institutions held 80,98,010 shares. The statutory auditors, M/s. R.B. Gohil & Co., reported no qualifications on the financial transactions. The disclosure was made to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Global Longlife Hospital & Research

1 Day5 Days1 Month6 Months1 Year5 Years
+3.86%+15.56%-4.56%-49.39%-52.48%-91.66%

What strategic rationale drove the approval to change the company's name and alter its object clause?

How will the re-appointment of the Managing Director and new Independent Directors influence the company's long-term strategic direction?

What specific new business areas will the company pursue following the alteration of the Memorandum of Association's object clause?

Global Longlife Hospital & Research
View Company Insights
View All News
like19
dislike

More News on Global Longlife Hospital & Research

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-52.48%